1. YAP/TAZ at the Roots of Cancer
   Francesca Zanconato et al, 2016, Cancer Cell CrossRef
2. Context-dependent roles of YAP/TAZ in stem cell fates and cancer
   Lucy LeBlanc et al, 2021, Cellular and Molecular Life Sciences CrossRef
3. TNFAIP8 interacts with LATS1 and promotes aggressiveness through regulation of Hippo pathway in hepatocellular carcinoma
   Qianze Dong et al, 2017, Oncotarget CrossRef
4. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer
   Qianze Dong et al, 2017, Oncotarget CrossRef
5. TMT‐based proteomics analysis of the effects of Qianjinweijing Tang on lung cancer
   Bingjie Huo et al, 2021, Biomedical Chromatography CrossRef
6. YAP knockdown inhibits proliferation and induces apoptosis of human prostate cancer DU145 cells
   Xin Jin et al, 2017, Molecular Medicine Reports CrossRef
7. Expression and Role of TRIM2 in Human Diseases
   Maolin Xiao et al, 2022, BioMed Research International CrossRef
8. Emerging Role of YAP and the Hippo Pathway in Prostate Cancer
   Filippos Koinis et al, 2022, Biomedicines CrossRef
9. Silencing circular RNA circZNF609 restrains growth, migration and invasion by up-regulating microRNA-186-5p in prostate cancer
   Chengjun Jin et al, 2019, Artificial Cells, Nanomedicine, and Biotechnology CrossRef
10. Targeting androgen-independent pathways: new chances for patients with prostate cancer?
    C. Cattrini et al, 2017, Critical Reviews in Oncology/Hematology CrossRef
11. Role of the Hippo signaling pathway in safflower yellow pigment treatment of paraquat-induced pulmonary fibrosis
    Hai Li et al, 2020, Journal of International Medical Research CrossRef
12. YAP1 Is Involved in Tumorigenic Properties of Prostate Cancer Cells
    Filiz Kisaayak Collak et al, 2020, Pathology & Oncology Research CrossRef
13. PTPN14 acts as a candidate tumor suppressor in prostate cancer and inhibits cell proliferation and invasion through modulating LATS1/YAP signaling
    Rong Wang et al, 2020, Molecular and Cellular Probes CrossRef
14. 17β-Estradiol, through activating the G protein-coupled estrogen receptor, exacerbates the complication of benign prostate hyperplasia in type 2 diabetes mellitus patients by inducing prostate proliferation
    Tingting Yang et al, 2024, Journal of Pharmaceutical Analysis CrossRef
15. The Hippo pathway in normal development and cancer
    Marcello Maugeri-Saccà et al, 2018, Pharmacology & Therapeutics CrossRef
16. Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer
    Filippos Koinis et al, 2020, Cancers CrossRef
17. Up regulation of the Hippo signalling effector YAP1 is linked to early biochemical recurrence in prostate cancers
    Andreas Marx et al, 2020, Scientific Reports CrossRef
18. Research advance and clinical implication of circZNF609 in human diseases
    Jieyi Luo et al, 2022, Biotechnology & Biotechnological Equipment CrossRef
19. Protein phase separation in cell death and survival
    Michael C. Chung et al, 2022, Mechanisms of Cell Death and Opportunities for Therapeutic Development CrossRef
20. Expression of netrin-1 by hypoxia contributes to the invasion and migration of prostate carcinoma cells by regulating YAP activity
    Haiwen Chen et al, 2016, Experimental Cell Research CrossRef
21. NEK1 Phosphorylation of YAP Promotes Its Stabilization and Transcriptional Output
    Md Imtiaz Khalil et al, 2020, Cancers CrossRef
22. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis
    Shuren Wang et al, 2016, Bioscience Reports CrossRef
23. The Hippo Pathway in Prostate Cancer
    null Salem et al, 2019, Cells CrossRef
24. The Extracellular Matrix Stiffening: A Trigger of Prostate Cancer Progression and Castration Resistance?
    Carole Luthold et al, 2022, Cancers CrossRef